Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and Progression

Early study of circulating tumor DNA for detection and monitoring of endometrial cancer recurrence and progression.

Cancers (Basel)PubMed 32785174DOI 10.3390/cancers12082231